GGrantIndex
Sort

40,608 grants matching prostate cancer

Advanced PET/CT Imaging for Improving Clincail Trials

$539,050
Paul E Kinahan · University Of Washington · U01 · FY2014 · CA

Development of Novel Targeted Therapeutic Agents for Castration Resistant Prostate Cancer

$539,006
Adegboyega Oyelere · Georgia Institute Of Technology · R01 · FY2023 · CA

Collaborative genomic alterations and transcriptional control in prostate cancer

$538,985
Christopher E Barbieri · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA

RISK FACTORS FOR ADVANCED PROSTATE CANCER

$538,915
University Of Southern California · R01 · FY2000 · CA

Biospeciman Core

$538,859
Robert Vessella · University Of Washington · P01 · FY2012 · CA

Optoacoustic system for image-guided biopsy of prostate cancer

$538,769
Alexander A Oraevsky · Fairway Medical Technologies, Inc. · R44 · FY2006 · CA

Breast Cancer PARP PET Imaging AIP to Support FDA Approval & Commercialization

$538,647
David A Mankoff · University Of Pennsylvania · R01 · FY2025 · CA

NOVEL TUMOR SUPPRESSIVE ROLE OF PHOSPHODIESTERASES IN PROSTATE CANCER

$538,577
Ohio State University, The · · FY2016 · Department of the Army

Longitudinal Imaging and Liquid Biopsy Markers of Prostate Cancer Radiotherapy Outcomes

$538,553
Alan Pollack · University Of Miami School Of Medicine · R01 · FY2025 · CA

Analysis of Human Immune Reponses in Cancer Vaccine Clinical Trials

$538,509
Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Role of Novel Cytokine-like Molecules Secretoglobin (SCGB) 3A1 and 3A2 in Lung

$538,486
Shioko Kimura · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Multidisciplinary Training in Image-Guided Therapy

$538,479
Ferenc A Jolesz · Brigham And Women'S Hospital · R25 · FY2008 · CA

Molecular Phenotyping and Image-Guidance for Surgical Treatment of High-Risk Prostate Cancer Using Ultrasmall Silica Nanoparticles

$538,399
Michelle S Bradbury · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA

Discovery of a novel MDM2-tubulin signaling pathway as a therapeutic target in AML

$538,185
Muxiang Zhou · Emory University · R01 · FY2025 · CA

New Tools for Prostate Cancer Detection and Prognostication

$538,172
Sanjiv S Gambhir · Stanford University · U01 · FY2012 · CA

Breast Cancer PARP PET Imaging AIP to Support FDA Approval & Commercialization

$538,137
David A Mankoff · University Of Pennsylvania · R01 · FY2024 · CA

Differential TGF-Beta Signaling in Bone Microenviroment: Impact on Tumor Growth

$537,945
Theresa A Guise · Indiana University Indianapolis · U01 · FY2012 · CA

Cancer Related Health Disparities Education and Career Development Program

$537,938
Jean Forster · University Of Minnesota · R25 · FY2013 · CA

Developing Functional Human Cell Models to Study Initiation and Progression of Prostate Cancer between AA and EA men

$537,842
Xuefeng Liu · Ohio State University · R01 · FY2023 · CA

Developing Functional Human Cell Models to Study Initiation and Progression of Prostate Cancer between AA and EA men

$537,842
Xuefeng Liu · Ohio State University · R01 · FY2025 · CA

Imaging Feedback to Guide Ultrasonic Tissue Fractionation for Cancer Therapy

$537,768
Charles Alan Cain · University Of Michigan At Ann Arbor · R01 · FY2009 · CA

H. LEE MOFFITT CANCER CENTER CCOP RESEARCH BASE

$537,759
University Of South Florida · U10 · FY2003 · CA

Determine the Role of Histone Methyltransferase ASH1L in Metastatic Prostate Cancer

$537,699
Di Zhao · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA

Determine the Role of Histone Methyltransferase ASH1L in Metastatic Prostate Cancer

$537,699
Di Zhao · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA

Radiation, Hormones & Antisense Prostate Cancer Therapy

$537,645
Alan Pollack · Fox Chase Cancer Center · R01 · FY2006 · CA